AZoNano on MSN5d
Reprogramming Liver Immunity: A Lipid Nanoparticle Approach for Pancreatic Cancer Therapy
A novel strategy using lipid nanoparticles to reprogram liver immunity shows promise in generating antitumor responses ...
Technology Networks3d
AstraZeneca's Drug Approved for Treating Limited-Stage Small Cell Lung Cancer in Europe
IMFINZITM (durvalumab) has received approval in the European Union as a monotherapy for treating adults with limited-stage ...
PipelineReview.com5d
Imfinzi approved in the EU as first and only immunotherapy for limited-stage small cell lung cancer
Approval based on ADRIATIC Phase III trial results which showed a 27% reduction in the risk of death versus placebo ...
Pharmabiz4d
EU approves AstraZeneca’s Imfinzi as monotherapy to treat adults with limited-stage small cell lung cancer
AstraZeneca’s Imfinzi (durvalumab) has been approved in the European Union (EU) as monotherapy for the treatment of adults with limited-stage small cell lung cancer (LS-SCLC) whose disease has not ...
Yahoo Finance4d
BriaCell Therapeutics Corp. (BCTX)
After hours: March 19 at 7:44:25 PM EDT Loading Chart for BCTX ...